HSBC HOLDINGS PLC - CUBIST PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of CUBIST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$1,075,000
+113.3%
10,676
+40.7%
0.00%
+100.0%
Q3 2014$504,000
-36.4%
7,586
-33.2%
0.00%
-50.0%
Q2 2014$792,000
-12.3%
11,349
-8.1%
0.00%0.0%
Q1 2014$903,000
-0.7%
12,346
-6.6%
0.00%0.0%
Q4 2013$909,000
+11.5%
13,214
+3.1%
0.00%0.0%
Q3 2013$815,000
+86.5%
12,821
+41.7%
0.00%
+100.0%
Q2 2013$437,000
+10.1%
9,047
+6.6%
0.00%0.0%
Q1 2013$397,000
+53.9%
8,486
+56.9%
0.00%0.0%
Q3 2012$258,0005,4070.00%
Other shareholders
CUBIST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AKANTHOS CAPITAL MANAGEMENT LLC 50,500$3,526,00010.49%
Palo Alto Investors LP 1,526,916$106,609,0007.94%
HealthCor Management, L.P. 1,225,000$85,530,0004.29%
SECTOR GAMMA AS 192,490$13,440,0003.18%
AMI ASSET MANAGEMENT CORP 363,698$25,393,0002.52%
EAGLE BOSTON INVESTMENT MANAGEMENT INC 578,207$40,370,0002.01%
TURNER INVESTMENTS LLC 559,239$39,046,0001.73%
Tekla Capital Management LLC 263,772$18,417,0001.69%
MAZAMA CAPITAL MANAGEMENT INC 80,221$5,601,0001.50%
WESTFIELD CAPITAL MANAGEMENT CO LP 3,234,570$225,838,0001.34%
View complete list of CUBIST PHARMACEUTICALS INC shareholders